1763.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 21:20):

Stats
Today's Volume	200.00
Average Volume	157 494
Market Cap	3.31B
EPS	HKD0 ( 2023-08-29 )
Last Dividend	HKD0.479 ( 2023-07-04 )
Next Dividend	HKD0 ( N/A )
P/E	7.44
ATR14	HKD0.0510 (0.49%)

Volume Correlation

Long: 0.10 (neutral)

Short: 0.00 (neutral)

Signal:(51.597) Neutral

China Isotope & Radiation Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

China Isotope & Radiation Correlation - Currency/Commodity

0.83
( strong )

0.86
( strong )

0.00
( neutral )

0.70
( moderate )

0.48
( neutral )

-0.26
( neutral )

China Isotope & Radiation Financials

Annual	2022
Revenue:	HKD6.15B
Gross Profit:	HKD3.51B (57.18 %)
EPS:	HKD1.220

Q2	2023
Revenue:	HKD2.74B
Gross Profit:	HKD1.48B (54.18 %)
EPS:	HKD0.400

Q4	2022
Revenue:	HKD3.53B
Gross Profit:	HKD1.98B (56.20 %)
EPS:	HKD0.880

Q2	2022
Revenue:	HKD2.62B
Gross Profit:	HKD1.53B (58.51 %)
EPS:	HKD0.350

Financial Reports:

No articles found.

China Isotope & Radiation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.479 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China Isotope & Radiation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.17 - Stable (3.48%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.169	2018-11-28
Last Dividend	HKD0.479	2023-07-04
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	HKD1.597	--
Avg. Dividend % Per Year	0.00%	--
Score	3.03	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.17
Div. Directional Score	8.22	--

Next Divdend (Est)
(2024-05-24)

HKD0.564 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.03

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6198.HK	Ex Dividend Knight	2023-06-08	Annually	0.00%
1890.HK	Ex Dividend Knight	2023-08-04	Annually	0.00%
0916.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
0052.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
2866.HK	Ex Dividend Junior	2023-07-06	Sporadic	0.00%
1461.HK	Ex Dividend Junior	2023-06-20	Sporadic	0.00%
0543.HK	Ex Dividend Junior	2023-05-17	Annually	0.00%
6969.HK	Ex Dividend Junior	2023-09-06	Semi-Annually	0.00%
1988.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
1066.HK	Ex Dividend Knight	2023-10-19	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0650	1.500	8.70	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0345	1.200	8.85	10.00	[0 - 0.3]
returnOnEquityTTM	0.0914	1.500	-0.0960	-0.144	[0.1 - 1]
payoutRatioTTM	0.297	-1.000	7.03	-7.03	[0 - 1]
currentRatioTTM	1.833	0.800	5.83	4.67	[1 - 3]
quickRatioTTM	1.477	0.800	6.02	4.81	[0.8 - 2.5]
cashRatioTTM	0.542	1.500	8.10	10.00	[0.2 - 2]
debtRatioTTM	0.0824	-1.500	8.63	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	2.06	2.00	9.31	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0215	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.218	-1.500	9.13	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.553	1.000	4.11	4.11	[0.2 - 0.8]
operatingProfitMarginTTM	0.142	1.000	9.15	9.15	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.677	1.000	7.35	7.35	[0.2 - 2]
assetTurnoverTTM	0.531	0.800	9.79	7.83	[0.5 - 2]
Total Score				11.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.50	1.000	9.34	0	[1 - 100]
returnOnEquityTTM	0.0914	2.50	-0.0617	-0.144	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0215	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	5.01	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.06	2.00	9.31	10.00	[0 - 30]
payoutRatioTTM	0.297	1.500	7.03	-7.03	[0 - 1]
pegRatioTTM	-0.232	1.500	-4.88	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.105	1.000	9.88	0	[0.1 - 0.5]
Total Score				5.17

China Isotope & Radiation

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services, and Other Business. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services, and Other Business segment provides independent clinical laboratory services with respect to hepatitis, endocrine, bone metabolism, cardiovascular disease, diabetes, and other diseases to hospitals and other medical institutions. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.